Cover Image
市場調查報告書

肛門癌:全球臨床實驗檢討

Anal Cancer Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 226843
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
肛門癌:全球臨床實驗檢討 Anal Cancer Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月19日 內容資訊: 英文 109 Pages
簡介

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 肛門癌
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 臨床實驗 ; G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗 ; E7 各國
  • 臨床實驗 各階段
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 肛門癌
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 肛門癌 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • Deutsche Luft und Raumfahrt
  • 臨床實驗概要; Deutsche Luft und Raumfahrt
  • MannKind Corporation
  • 臨床實驗概要; MannKind Corporation
  • GlaxoSmithKline plc
  • 臨床實驗概要; GlaxoSmithKline plc
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Stanford University
  • 臨床實驗概要; Stanford University
  • The University of Texas M. D. Anderson Cancer Center
  • 臨床實驗概要; The University of Texas M. D. Anderson Cancer Center
  • Radiation Therapy Oncology Group
  • 臨床實驗概要; Radiation Therapy Oncology Group
  • European Organization for Research and Therapeutics of Cancer
  • 臨床實驗概要; European Organization for Research and Therapeutics of Cancer
  • University Health Network
  • 臨床實驗概要; University Health Network
  • Memorial Sloan Kettering Cancer Center
  • 臨床實驗概要; Memorial Sloan Kettering Cancer Center
  • Federation Nationale des Centres de Lutte Contre le Cancer
  • 臨床實驗概要; Federation Nationale des Centres de Lutte Contre le Cancer
  • The National Institute of Allergy and Infectious Diseases
  • 臨床實驗概要; The National Institute of Allergy and Infectious Diseases
  • Mayo Clinic
  • 臨床實驗概要; Mayo Clinic
  • University College London (UCL) Cancer Institute
  • 臨床實驗概要; University College London (UCL) Cancer Institute
  • Alberta Health Services
  • 臨床實驗概要; Alberta Health Services
  • Southeastern Medical Oncology Center
  • 臨床實驗概要; Southeastern Medical Oncology Center
  • Jewish General Hospital
  • 臨床實驗概要; Jewish General Hospital
  • The University of North Carolina
  • 臨床實驗概要; The University of North Carolina
  • University of California, Los Angeles
  • 臨床實驗概要; University of California, Los Angeles
  • Southern California Institute for Research and Education
  • 臨床實驗概要; Southern California Institute for Research and Education
  • Copenhagen University Hospital at Herlev
  • 臨床實驗概要; Copenhagen University Hospital at Herlev
  • The University of Texas Medical Branch at Galveston
  • 臨床實驗概要; The University of Texas Medical Branch at Galveston
  • Centre hospitalier de l'Universite de Montreal
  • 臨床實驗概要; Centre hospitalier de l'Universite de Montreal
  • University of Oxford
  • 臨床實驗概要; University of Oxford

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 肛門癌 全球治療藥物市場, 臨床實驗 各地區
  • 肛門癌 全球治療藥物市場, 臨床實驗 各國排名
  • 肛門癌 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 肛門癌 治療藥物的臨床實驗, 亞太地區,前幾名國家
  • 肛門癌 治療藥物的臨床實驗, 歐洲, 前五國
  • 肛門癌 治療藥物的臨床實驗, 北美, 前幾名國家
  • 肛門癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 肛門癌 治療藥物的臨床實驗, G7 各國
  • 肛門癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 肛門癌 治療藥物的臨床實驗, E7 各國
  • 肛門癌 全球治療藥物市場, 臨床實驗 各階段
  • 肛門癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 肛門癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 肛門癌 全球治療藥物市場, 一時中止的臨床實驗
  • 肛門癌 全球治療藥物市場, 中止的臨床實驗
  • 肛門癌 全球治療藥物市場, 終止的臨床實驗
  • 肛門癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 肛門癌 全球治療藥物臨床實驗, 主要的贊助商
  • 肛門癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 肛門癌 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Deutsche Luft und Raumfahrt
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; MannKind Corporation
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; GlaxoSmithKline plc
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Stanford University
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The University of Texas M. D. Anderson Cancer Center
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Radiation Therapy Oncology Group
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; European Organization for Research and Therapeutics of Cancer
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University Health Network
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Memorial Sloan Kettering Cancer Center
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Federation Nationale des Centres de Lutte Contre le Cancer
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The National Institute of Allergy and Infectious Diseases
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Mayo Clinic
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University College London (UCL) Cancer Institute
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Alberta Health Services
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Southeastern Medical Oncology Center
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Jewish General Hospital
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The University of North Carolina
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University of California, Los Angeles
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Southern California Institute for Research and Education
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Copenhagen University Hospital at Herlev
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; The University of Texas Medical Branch at Galveston
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; Centre hospitalier de l'Universite de Montreal
  • 肛門癌 全球治療藥物臨床實驗市場, 臨床實驗 ; University of Oxford

圖表一覽

  • 肛門癌 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 肛門癌 全球治療藥物市場, 臨床實驗 各國排名
  • 肛門癌 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 肛門癌 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 肛門癌 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
  • 肛門癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
  • 肛門癌 治療藥物的臨床實驗, G7 各國 (%)
  • 肛門癌 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 肛門癌 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 肛門癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 肛門癌 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 肛門癌 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 肛門癌 全球治療藥物臨床實驗, 主要的贊助商
  • 肛門癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 肛門癌 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3392CTIDB

GlobalData's clinical trial report, "Anal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Anal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures >
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Anal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Anal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Anal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Anal Cancer Therapeutics, Global, Clinical Trials by Region, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Anal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Anal Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Anal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Anal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Anal Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Anal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Anal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Anal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Anal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Anal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Anal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Anal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Anal Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Anal Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Anal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Anal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Anal Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Anal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Anal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Anal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Anal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Anal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top